Welcome

Leeds ECMC draws on the scientific framework from four Yorkshire universities (Leeds, Bradford, Hull and York) with the aim of developing of new ways of treating and monitoring cancer. The Centre has wide experience of first-in-man and proof-of-principle early clinical trials of small molecules and biotherapies, both as single agents and in combination. Developing prognostic and predictive cancer biomarkers is another focus area.